Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
7wireVentures
AddedFeb 13, 2024
UpdatedJun 28, 2026
7wireVentures

7wireVentures

Operating

7Wire Ventures: A global venture capital firm investing in early-stage digital health companies.

Location
Chicago, IL, US
Founded
2011
Firm
Compare
Portfolio
Employees
Website

Investments

Vivante Health
Vivante Health

Total Raised

$58.8M

Rounds

4

Series B$31MSeptember 2023
Series A$16MMarch 2022
Caraway
Caraway

Total Raised

$97.5M

Rounds

5

Series A$16.8MJune 2023
Seed$10.5MJuly 2022
Nocd
Nocd

Total Raised

$84M

Rounds

6

Series B$34MJanuary 2023
Series B$33MSeptember 2021
Override
Override

Total Raised

$4.5M

Rounds

2

Seed$3.5MDecember 2022
PayZen
PayZen

Total Raised

$240M

Rounds

5

Series B$20MNovember 2022
Series A$15MNovember 2021
Folx Health
Folx Health

Total Raised

$59.4M

Rounds

4

Series B$30MOctober 2022
Homethrive
Homethrive

Total Raised

$38M

Rounds

2

Series B$20MMay 2022
9amHealth
9amHealth

Total Raised

$19.7M

Rounds

3

Series A$16MApril 2022
Brightline
Brightline

Total Raised

$212M

Rounds

6

Series C$105MMarch 2022
Series B$65MJune 2021
Global Pain Center
Global Pain Center

Total Raised

$4.5M

Rounds

1

Seed$4.5MMarch 2022
Jasper Health
Jasper Health

Total Raised

$31.8M

Rounds

2

Series A$25MFebruary 2022
Seed$6.8MMarch 2021
Transcarent
Transcarent

Total Raised

$298M

Rounds

3

Series C$200MJanuary 2022
Series B$58MJune 2021
MedArrive
MedArrive

Total Raised

$70.3M

Rounds

5

Series A$25MNovember 2021
Zerigo Health
Zerigo Health

Total Raised

$67.4M

Rounds

11

Series B$43MOctober 2021
RecoveryOne
RecoveryOne

Total Raised

$50.2M

Rounds

4

Series C$33MSeptember 2021
BioIntelliSense
BioIntelliSense

Total Raised

$84.8M

Rounds

4

Series B$45MJuly 2021
CirrusMD
CirrusMD

Total Raised

$47.6M

Rounds

7

Series C$20MMarch 2021
Medisafe
Medisafe

Total Raised

$51.5M

Rounds

5

Series C$30MFebruary 2021